IFNA1 and systemic lupus erythematosus: The major concern of using the IFN signature for SLE diagnosis is specificity, because activation of the type I IFN pathway has been reported in other conditions, including rheumatoid arthritis, myositis, and primary Sjögren’s syndrome (41).